Alkermes
growth presents additional long term revenue opportunity monthly novel oral fumarate for the treatment of relapsing forms of multiple sclerosis biogen holds exclusive license to commercialize royalty to alkermes on net sales oral market mar may june data i | Alkermes
Company
Deck Type
Sector
Industry
Deck date
March 2021
Slide
22 of 144
Related slides by other companies
Voyager Digital
Investor Presentation
June 2022
sept march competitive apple store rankings finance voyager consistently ranked third among first after and | Voyager Digital
AbCellera
Investor Presentation
February 2024
deepening stakes evidenced by strong growth of royalty rates | AbCellera
Waldencast
SPAC
April 2022
we have a broad and comprehensive set of patents creating a strategic moat and high barriers to entry | Waldencast
Voyager Digital
Investor Presentation
March 2022
competitive apple store rankings finance | Voyager Digital
Other recent decks by Alkermes
See all presentations (22 decks)
Investor Conference
January 2024
Results
October 2023
Investor Presentation
October 2023
Results
July 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io